Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001062993-24-015470
Filing Date
2024-08-20
Accepted
2024-08-20 20:13:16
Documents
14
Group Members
ADVENT LIFE SCIENCES FUND II LPDOMINIC SCHMIDTKAASIM MAHMOODRAJESH PAREKHSHAHZAD MALIK

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A formsc13da.htm SC 13D/A 100732
2 EXHIBIT 1 exhibit1.htm EX-1 5716
3 GRAPHIC exhibit1xz001.jpg GRAPHIC 2039
4 GRAPHIC exhibit1xz002.jpg GRAPHIC 2039
5 GRAPHIC exhibit1xz003.jpg GRAPHIC 2039
6 GRAPHIC exhibit1xz004.jpg GRAPHIC 1713
7 GRAPHIC exhibit1xz005.jpg GRAPHIC 2717
8 GRAPHIC exhibit1xz006.jpg GRAPHIC 2064
9 GRAPHIC formsc13daxu001.jpg GRAPHIC 2039
10 GRAPHIC formsc13daxu002.jpg GRAPHIC 2039
11 GRAPHIC formsc13daxu003.jpg GRAPHIC 2039
12 GRAPHIC formsc13daxu004.jpg GRAPHIC 1713
13 GRAPHIC formsc13daxu005.jpg GRAPHIC 2717
14 GRAPHIC formsc13daxu006.jpg GRAPHIC 2064
  Complete submission text file 0001062993-24-015470.txt   144996
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-56243 | Film No.: 241226897
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND
Business Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND 44 (0) 207 932 2120
Advent Life Sciences LLP (Filed by) CIK: 0001601364 (see all company filings)

EIN.: 000000000
Type: SC 13D/A